Literature DB >> 25145650

Rapid or normal gastric emptying as new supportive criteria for diagnosing cyclic vomiting syndrome in adults.

Chad J Cooper1, Sarmad Said1, Jorge Bizet1, Haider Alkahateeb1, Irene Sarosiek1, Richard W McCallum1.   

Abstract

BACKGROUND: Cyclic vomiting syndrome (CVS) in adults is a disorder characterized by recurrent and stereotypic episodes of severe nausea, vomiting and abdominal pain separated by symptom-free intervals. Our goal was to investigate gastric emptying (GE) in CVS patients.
MATERIAL AND METHODS: This was a retrospective study of 30 adult patients who met Rome III diagnostic criteria for CVS. Rapid GE was defined using two different predefined criteria as either <50% isotope retention or <65% isotope retention at 1st hour and/or <20% at 2nd hour.
RESULTS: Of the 30 patients (25 had 4-hr GE) diagnosed with CVS, 22 were females and 8 males with a mean age of 39 years. Overall, 20 (80%) of the 25 CVS patients met the predefined criteria of <50% retention for rapid GE in the first hour. Fifteen (60%) met the 2-hour criteria for rapid emptying of <20% retention. Five (16.6%) patients of the 25 had a normal GE with a mean retention at the first hour of 65% (52-78%). Nine (36%) also met another predefined criteria of <35% retention for rapid GE in the first hour. Sixteen (64%) met criteria for normal GE.
CONCLUSIONS: (1) In adult CVS patients, GE is either rapid or normal, clearly distinguishing this entity from gastroparesis. (2) Cyclic vomiting syndrome is an important new etiology to explain the finding of rapid GE on a radionuclide test. (3) We suggest that rapid gastric emptying should be added as supportive criteria for diagnosing CVS in adults.

Entities:  

Mesh:

Year:  2014        PMID: 25145650      PMCID: PMC4152253          DOI: 10.12659/MSM.890547

Source DB:  PubMed          Journal:  Med Sci Monit        ISSN: 1234-1010


Background

Cyclic vomiting syndrome (CVS) is an idiopathic disorder that is characterized by relentless bouts of vomiting separated by symptom free intervals. The etiology and pathogenesis of CVS remain unknown. It was first described in children, but has increasingly been more recognized in adults. It has been estimated that up to 1.6% of children experience symptoms consistent with this disorder, but the prevalence in adults is unknown [1]. Recent referral patterns suggest a prevalence approximating 0.2% in the adult population. CVS has an average age of onset of 35 years old but these patients are not actually diagnosed until about 41 years old with no predilection for a specific gender. Functional gastrointestinal (GI) disorders are comprised of symptoms arising in the GI tract that are not otherwise attributable to a known structural or biochemical explanation [2]. CVS is a functional gastrointestinal disorder in which the diagnosis is made clinically based on the criteria set forth by the consensus of expert opinion in the Rome III Criteria for Functional Gastrointestinal Disorder (Table 1) [3].
Table 1

Rome III Diagnostic Criteria for CVS.

Must be at least three months, with the onset at least six months previously of:
1. Stereotypical episodes of vomiting regarding the acute onset and duration being <1 week
2. Three or more discrete episodes in the prior year
3. Absence of nausea and vomiting between episodes
4. Absence of any organic cause of vomiting
5. Supportive Criteria: Either a prior history or family history of migraine headaches
CVS consists of four phases: inter-episodic, prodromal, emetic and recovery phase. Recognition of this pattern of phases can help in making the diagnosis and in management. The inter-episodic phase is relatively symptom-free. The prodrome begins when the patient can sense the approach of an episode but can still tolerate oral intake. The vomiting or emetic phase is characterized by intense, persistent nausea, vomiting and other symptoms. The recovery phase begins with the remission of the nausea and vomiting and terminates when the patient has fully recovered [4]. The best treatment is to prevent the episodes of CVS by initiating a daily therapy regimen [5]. CVS can range from a mild disease with infrequent episodes to severe and debilitating disease that leads to frequent emergency department visits and hospitalizations. The frequency of CVS episodes averages about 12 episodes per year [6]. Over time without appropriate treatment the episodes begin to coalesce and then there is the perception of more chronic symptoms with few asymptomatic of “remission” days. The majority of cyclic vomiting attacks have been associated with a physiologic trigger mechanism. These include infection, psychological stress, physical stress, lack of sleep, poor diet and onset of menses. Migraine headaches, anxiety and depression are frequently reported to coexist with CVS [7]. Cyclic vomiting syndrome in adults has some different characteristics than children with the following hallmarks: 1) prominence of accompanying epigastric or diffuse abdominal pain; 2) increased prevalence of anxiety and depression; 3) normal or rapid gastric emptying and tachygastric electrogastrogram (EGG) findings and 4) successful suppression of attacks by chronic amitriptyline therapy [8]. The diagnosis of CVS is primarily based on history and clinical presentation. Increased awareness of the condition and a high index of suspicion may help decrease delay in diagnosis after symptom onset [9]. Making a definitive diagnosis of CVS requires the exclusion of other disorders associated with recurrent vomiting. Many medications can cause nausea and vomiting and most recently chronic daily marijuana use has been identified as inducing cyclical hyperemesis [10]. Due to the frequent misdiagnosis of CVS, the patient can be exposed to many unnecessary diagnostic tests and is therefore not initially treated appropriately. There is an emerging consensus that CVS appears to involve dysregulated central neural pathways and neuro-endocrine mediators involved in the afferent and efferent brain – gut pathways of nausea and vomiting [11]. CVS is a functional brain-gut disorder that involves peripheral gastrointestinal mediation and central neuroendocrine [12,13]. Venkatesan et al. revealed that 90% of CVS patient in their study had evidence of sympathetic dysfunction [14]. No patients were found to have parasympathetic dysfunction. Their study suggests that sympathetic dysfunction plays an important role in CVS. Understanding why CVS patients have a rapid gastric emptying study (GES) in the vomiting free period suggests that an underlying autonomic dysfunction exists. Humoral factors and hormones have also been postulated to explain the rapid GES. There are reports suggesting that patients with CVS have either a rapid or normal gastric empting result [3,15]. This finding is important in being able to differentiate the entity of CVS from gastroparesis because symptoms can become very similar as the CVS attacks become more frequent [15]. Hence our goal was to investigate gastric emptying in a population of CVS patients in order to further understand the spectrum and characteristics of gastric emptying in CVS patients.

Material and Methods

Patients with the primary diagnosis of CVS were eligible for participation in the research study. For our retrospective study, thirty medical charts were reviewed of patients who met Rome III diagnostic criteria for CVS (Table 1) and presented for a new visit or follow up to Texas Tech University clinic of Gastroenterology in El Paso, Texas from 2009 to 2012. The study protocol was approved by the Institutional Review Board (IRB) of Texas Tech University Health Sciences Center of El Paso, Texas. Demographic data, comorbiities, GES results and amitriptyline dose were recorded.

Gastric emptying study

Gastric emptying time (GET) was assessed by standard 4-h scintigraphic method using a low fat solid meal. Scintigraphic GET was performed during the remission or quiescent stage of their disease. Patients were instructed to fast overnight and stop prokinetics and proton pump inhibitors (PPI) for at least 3 days and narcotic medication were withheld for more than 12 h. For diabetic patients, the glucose level had to be <250 mg/dL at the start of the meal or it was rescheduled unless glucose levels could be reduced. A standardized scintigraphic gastric emptying protocol involving a low fat (2%) isotope labeled egg white meal of 250 Kcal was performed. Anterior and posterior gastric images in the standing position were obtained at 0, 1, 2, 4 h after meal ingestion. During the 4 h of the assessment all patients remained upright, either walking or sitting. There was no reclining or sleep permitted. Normal GE was defined as < 90% retention at 1 h, < 60% at 2 h, and <10% at 4 h. Rapid GE was defined using two different predefined criteria as either <50% isotope retention or <65% isotope retention at 1st hour and/or <20% at 2nd hour. Delayed gastric retention was defined as a delay of greater than 90% at 1 h, 60% at 2 h, and >10% at 4 h based on normal data established for this standardized GES. The GET results were interpreted by the Texas Tech University of El Paso Department of Nuclear Medicine. A medical chart review was required to obtain prior gastric emptying study results and any additional data.

Statistical analysis

Descriptive statistics are presented as means or percentage for variables measured on a continuous scale (e.g., age) and as proportions for variables measured on a discrete scale (e.g., gender).

Results

Overall, 30 patient medical charts were analyzed in those diagnosed with CVS between the years 2009–2012. This included 22 females and 8 males with a mean age of 39 years (19 to 68 years). All patients reported nausea, vomiting and mid-epigastric pain. The majority of patients reported monthly episodes of cyclic vomiting that lasted for at least 5 days. Comorbidities included diabetes mellitus (30%), hypertension (30%), hyperlipidemia (26.6%), anxiety (46.6%), depression (36.6%), migraines (36.6%), panic disorder (6.6%), and chronic daily marijuana use (30%) for more than 5 years. Overall, 20 (80%) of the 25 CVS patients met the predefined criteria of <50% retention for rapid GE in the first hour with a mean retention of isotope at 1st hour of 31.3% (25–49%) (Figure 1, Tables 2, 3). Fifteen (60%) met the 2-hour criteria for rapid emptying with a mean retention of 11.4% (5–17%). Five (16.6%) patients of the 25 had a normal GE with a mean retention at the first hour of 65% (52–78%) (Table 4). Nine (36%) met the predefined criteria of <35% retention for rapid GE in the first hour. The remaining sixteen (64%) patients met criteria for normal GE. Interestingly 19 (70%) of the patients were being treated with amitriptyline in doses ranging from 10 mg to 200 mg at night at the same time of the GE study.
Figure 1

Mean GET for normal and rapid GE based on <50% retention criteria.

Table 2

Summary of GET results (1, 2, 4 hours) based on the <50% retention criteria.

Mean GET% retentionNormal GET (n=5), mean (range)Rapid GET (n=20), mean (range)
1st hr65% (52–78%)31.3% (25–49%)
2nd hr43% (31–63%)11.4% (5–17%)
4th hr7% (0–10%)1% (0–9%)
Table 3

% Patients with rapid (<50% retention at 1st hour) or normal GE.

Rapid GES at 1st hour80% (n=20)
Rapid GES at 2nd hour60% (n=15)
Normal GES16.6% (n=5)
Table 4

% Patients with rapid (<35% retention at 1st hour) or normal GE.

Rapid GES at 1st hour36% (n=9)
Normal GES64% (n=16)

Discussion

Our study, demonstrates that up to 80% of our adult patients with CVS had a rapid GE accounting with 16.6% being normal when using the <50% retention criteria. When using the <35% retention criteria 36% had a rapid GE and 64% had a normal GE. This data signals that CVS is a new addition to the differential diagnosis of rapid GE. This observation is very relevant for clinicians who may already suspect the diagnosis of CVS when evaluating patients with a questionable vomiting presentation. Identifying rapid or normal GE would provide confirmatory evidence of CVS and set the stage for initiating appropriate medical treatment by defiantly excluding the possibility of gastroparesis. This is particularly relevant in diabetics or when cycles of vomiting are becoming more frequent and gastroparesis is raised as a differential diagnosis. Gastric emptying studies should be performed during the remission phase when there are minimal or no symptoms and no narcotic medications are being received [16]. Patients hospitalized with CVS that are given narcotics can have a falsely delayed GE. Understanding why there is a rapid GE during a vomiting free period has led to speculation and support for an underlying autonomic dysfunction is these patients [1,17]. Cyclic vomiting syndrome is an uncommon diagnosis, however with improved awareness it is being recognized more in adults. However, there is still a significant delay between onset of symptoms and diagnosis in adults. CVS should be considered in the initial diagnostic evaluation for unrelenting nausea and vomiting and accompanying abdominal pain without another explanation. Increased awareness of this disorder can lead to a reduction in invasive and costly diagnostic workups. The clinical relevance of our study is that a rapid GE should alert the clinician to consider CVS in the differential diagnosis. We also recommend further prospective studies in larger populations and multiple centers with standard radionuclide 4-hour GET to better evaluate this observation. In adult CVS patients, GE is either rapid or normal, clearly distinguishing this entity from gastroparesis. The mechanism of why cyclic vomiting syndrome patients have a rapid GE is unknown but warrants future investigation.

Conclusions

Cyclic vomiting syndrome is an important new etiology to explain the finding of rapid GE on a radionuclide test. One hundred percent of CVS patients have either rapid or normal GE. This is a “signature” finding separating CVS from gastroparesis and hence we recommend that GE status be added as one of the criteria for the diagnosis of CVS.
  16 in total

1.  Familial cyclic vomiting syndrome.

Authors:  J Haan; E E Kors; M D Ferrari
Journal:  Cephalalgia       Date:  2002-09       Impact factor: 6.292

2.  Cyclic vomiting syndrome and functional vomiting in adults: association with cannabinoid use in males.

Authors:  R S Choung; G R Locke; R M Lee; C D Schleck; A R Zinsmeister; N J Talley
Journal:  Neurogastroenterol Motil       Date:  2011-09-27       Impact factor: 3.598

3.  Elevated serum ghrelin levels in adult patients with cyclic vomiting syndrome.

Authors:  Reza A Hejazi; Teri H Lavenbarg; Richard W McCallum
Journal:  Am J Gastroenterol       Date:  2011-10       Impact factor: 10.864

4.  Spectrum of gastric emptying patterns in adult patients with cyclic vomiting syndrome.

Authors:  R A Hejazi; T H Lavenbarg; R W McCallum
Journal:  Neurogastroenterol Motil       Date:  2010-08-19       Impact factor: 3.598

5.  Autonomic nerve function in adult patients with cyclic vomiting syndrome.

Authors:  R A Hejazi; T H Lavenbarg; M Pasnoor; M Dimachkie; P Foran; L Herbelin; R W McCallum
Journal:  Neurogastroenterol Motil       Date:  2011-02-16       Impact factor: 3.598

6.  Similarities in cyclic vomiting syndrome across age groups.

Authors:  C Prakash; A Staiano; R J Rothbaum; R E Clouse
Journal:  Am J Gastroenterol       Date:  2001-03       Impact factor: 10.864

7.  Autonomic nerve function in adults with cyclic vomiting syndrome: a prospective study.

Authors:  T Venkatesan; T Prieto; A Barboi; B Li; A Schroeder; W Hogan; A Ananthakrishnan; S Jaradeh
Journal:  Neurogastroenterol Motil       Date:  2010-12       Impact factor: 3.598

Review 8.  Cyclic vomiting syndrome in adults.

Authors:  T L Abell; K A Adams; R G Boles; A Bousvaros; S K F Chong; D R Fleisher; W L Hasler; P E Hyman; R M Issenman; B U K Li; S L Linder; E A Mayer; R W McCallum; K Olden; H P Parkman; C D Rudolph; Y Taché; S Tarbell; N Vakil
Journal:  Neurogastroenterol Motil       Date:  2008-04       Impact factor: 3.598

Review 9.  Cyclic vomiting syndrome: what a gastroenterologist needs to know.

Authors:  Namita Pareek; David R Fleisher; Thomas Abell
Journal:  Am J Gastroenterol       Date:  2007-12       Impact factor: 10.864

10.  Cyclic vomiting syndrome developed after stroke.

Authors:  Kwang Lae Lee; Jung In Shin
Journal:  Ann Rehabil Med       Date:  2012-02-29
View more
  5 in total

1.  Clinical Predictors of Rapid Gastric Emptying in Patients Presenting with Dyspeptic Symptoms.

Authors:  Juan Gomez Cifuentes; Mark Radetic; Rocio Lopez; Scott Gabbard
Journal:  Dig Dis Sci       Date:  2019-04-13       Impact factor: 3.199

Review 2.  Cannabinoid Hyperemesis Syndrome: A Review of Potential Mechanisms.

Authors:  Marieka V DeVuono; Linda A Parker
Journal:  Cannabis Cannabinoid Res       Date:  2020-06-05

Review 3.  Gastroparesis.

Authors:  Michael Camilleri; Victor Chedid; Alexander C Ford; Ken Haruma; Michael Horowitz; Karen L Jones; Phillip A Low; Seon-Young Park; Henry P Parkman; Vincenzo Stanghellini
Journal:  Nat Rev Dis Primers       Date:  2018-11-01       Impact factor: 52.329

Review 4.  Cannabinoid hyperemesis and the cyclic vomiting syndrome in adults: recognition, diagnosis, acute and long-term treatment.

Authors:  Christian G Blumentrath; Boris Dohrmann; Nils Ewald
Journal:  Ger Med Sci       Date:  2017-03-21

Review 5.  Cyclic vomiting syndrome: a case series and review of the literature.

Authors:  Jessica Shearer; Pavit Luthra; Alexander C Ford
Journal:  Frontline Gastroenterol       Date:  2016-05-27
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.